Official Title
Evaluate the Effectiveness for Long-term Consequences of COVID-19 of Mindfulness-based Stress Reduction (MBSR)
Brief Summary

The consequences of the Intensive Care Unit and the Covid-19 disease are still uncertain.However, many studies are bringing out often psychological and dramatic consequences formany COVID-survivor patients.Among the ex-covid patients discharged from our Intensive Care Unit and with at least onecovid-related psychological consequence, we want to evaluate the effectiveness forlong-term consequences of COVID-19 of mindfulness-based stress reduction (MBSR) or usualcare.

Detailed Description

Randomized controlled clinical study. All patients who survived COVID-19 and discharged
from the intensive care unit of the Lecco hospital will be enrolled if present: chronic
pain, anxiety, depression and/or insomnia in pharmacological therapy A group of patients
will be observed during 12 months and evaluated with rating scales for chronic pain,
anxiety, depression and insomnia.

The second (experimental) group will receive psychotherapy (mindfulness-based stress
reduction and cognitive behavioral therapy) in addition to the pharmacological therapy

Recruiting
Post Acute COVID-19 Syndrome

Behavioral: mindfulness-based stress reduction (MBSR) and cognitive behavioral therapy (CBT)

Patients with long-term consequences of COVID-19 (Chronic pain, anxiety, depression or
insomnia) enrolled and randomly assigned to receive MBSR (n = 63), or usual care (n =
62). MBSR (training in mindfulness meditation and yoga) were delivered in 12 months with
2-hour groups each 2 months. Usual care included anything care participants received such
as drug therapy.

Eligibility Criteria

Inclusion Criteria:

- Intensive care survivors

- Surviving COVID-19 patients

- Patients with Chronic Pain Anxiety Depression and/or Insomnia in drug therapy

Exclusion Criteria:

- Patients with Chronic Pain Anxiety Depression and/or Insomnia NOT in drug therapy

- Patients not hospitalized in intensive care for COVID-19

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
Italy
Locations

ASST Lecco
Lecco, Italy

Investigator: VINCENZO LC DAMICO
Contact: 3409297118
vi.damico@asst-lecco.it

Contacts

Vincenzo LC Damico, PhD
+39 3409297118 - LC
vi.damico@asst-lecco.it

Vincenzo Damico, Principal Investigator
Azienda Socio Sanitaria Territoriale di Lecco

Azienda Socio Sanitaria Territoriale di Lecco
NCT Number
MeSH Terms
COVID-19
Post-Acute COVID-19 Syndrome